Back to Search
Start Over
Effect of prior pharmacotherapy on remission with sequential bilateral theta-burst versus standard bilateral repetitive transcranial magnetic stimulation in treatment-resistant late-life depression.
- Source :
- British Journal of Psychiatry; Nov2023, Vol. 223 Issue 5, p504-506, 3p
- Publication Year :
- 2023
-
Abstract
- Summary: Repetitive transcranial magnetic stimulation (rTMS) is used for treatment of late-life depression. In the FOUR-D study, sequential bilateral theta-burst stimulation (TBS) had comparable remission rates to standard bilateral rTMS. Data were analysed from the FOUR-D trial to compare remission rates between two types of rTMS based on the number and class of prior medication trials. The remission rate was higher in participants with ≤1 previous trial (43.9%) than in participants with 2 previous trials (26.5%) or ≥3 previous trials (24.6%; χ² = 6.36, d.f. = 2, P = 0.04). Utilising rTMS earlier in late-life depression may lead to better outcomes. [ABSTRACT FROM AUTHOR]
- Subjects :
- TRANSCRANIAL magnetic stimulation
MENTAL depression
DRUG therapy
Subjects
Details
- Language :
- English
- ISSN :
- 00071250
- Volume :
- 223
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- British Journal of Psychiatry
- Publication Type :
- Academic Journal
- Accession number :
- 173363497
- Full Text :
- https://doi.org/10.1192/bjp.2023.81